Yes we cann!
Taking cannabinoids to the next level
We SUPPORT THE NATURAL APPROACH TO MAINTAIN OUR HEALTH - WITH CANNABINOIDS







WE STRIVE TO MAINTAIN THE ENDOCANNABINOID SYSTEM
The endocannabinoid system or ECS for short resides within all animals except insects and is a 600-million-year-old messenger and receptor system integral to homeostasis. It is key to the management of balance within our body. From embryonic development to immunosurveillance, there is not a single function in our bodies that is not influenced or modulated by the ECS.
The ECS appears as a switchboard functioning in and across all physiologic processes and organs, acting and reacting to internal and external stimuli to direct, correct and overall manage our health.
The ECS can be broken down into core components. Cannabinoid receptors like CB1 and CB2. Ligands called endocannabinoids that bind to those receptors and initiate an action, such as anandamide and 2-AG. Enzymes that synthesize these endocannabinoids on demand when they’re needed and break them down after they’re used.
Hundreds of plant based cannabinoids found in cannabis and other plants that mimic or modulate our endocannabinoids have the potential to supplement the endocannabinoid system in therapeutic manners.
The main contributors to ECS dysfunctioning and disease are related to our lifestyle including high stress levels, unhealthy nutrition and lack of cannabimimetic practices, such as sleeping, exercising, deep breathing and social interactions.
Caring for ourself and our endocannabinoid system requires understanding of what nurtures it and what restores it. We are eager to provide our community with a great range of cannabinoid based products to maintain a healthy lifestyle.
What is the ECS?
How does the ECS work?
The ECS appears as a switchboard functioning in and across all physiologic processes and organs, acting and reacting to internal and external stimuli to direct, correct and overall manage our health. The ECS can be broken down into core components. Cannabinoid receptors like CB1 and CB2. Ligands called endocannabinoids that bind to those receptors and initiate an action, such as anandamide and 2-AG. Enzymes that synthesize these endocannabinoids on demand when they’re needed and break them down after they’re used.
How can we interact with the ECS?
Hundreds of plant based cannabinoids found in cannabis and other plants that mimic or modulate our endocannabinoids, have the potential to supplement the endocannabinoid system in therapeutic manners and facilitate our natural physiological function.
How can we help the ECS?
The main contributors to ECS dysfunctioning and disease are related to our lifestyle including high stress levels, unhealthy nutrition and lack of cannabimimetic practices, such as sleeping, exercising, deep breathing and social interactions. Caring for ourself and our endocannabinoid system requires understanding of what nurtures it and what restores it. We are eager to provide our community with a great range of cannabinoid based products to maintain a healthy lifestyle.
We foster business development in the cannabinoid space
We CREATE VALUE
In a rapidly developing time, values are fundamentally important to ensure the trust of our partners and customers. They provide the context and meaning to our activities.
As entusiastic as we are for the topic, ethics and scientific evidence are the foundation of our decisions.
Sustainability
We keep it green and simple - for our future generations
Innovation
We create new products, because state of the art is already history
Connectivity
We connect all stakeholders to ensure maximum quality
Passion
We are passionate to create value for our community, because we care.
WE ARE
SBR DEVELOPMENT HOLDING
Together as a team, we are better individuals. We strongly believe that the best investment is peoples education. Not only facts but social skills are what makes us a better team. People management and support in all parts of life creates a flourishing environment to achieve greatness.
Philip Schmiedhofer, MSc
Philip Schmiedhofer is an austrian neuroscientist and the managing director of SBR Development Holding GmbH, cannhelp GmbH and cannmedic GmbH. He holds a bachelor’s degree in biomedical engineering and a master’s degree in molecuar biology. His top knowledge lies in the development of medical technology and research with cannabinoids in the field of neuroscience. His inquiring mind can now incorporate his findings, the effects of cannabinoids within the central nervous system, into the development of innovative cannabinoid-based products. As co-founder and CEO he has been an entrepreneur since 2015 and has an extensive network in the medical field. In addition to the management and sales of medical devices, his main focus is business development, quality management and the distribution of medical products. As a consultant he actively consults internationally active pharmaceutical companies in the cannabinoid field.
Thomas Bibaritsch, Dipl.-Ing.
Thomas holds a customized master’s degree in environmental sciences from the University of Natural Resources and Life Sciences, Vienna. His academic background led him early on to recognize the diverse societal potential of CBD and industrial hemp. From the very beginning of cannhelp, he was driven by the vision of promoting the hemp plant’s ecological benefits for sustainable agriculture. As co-founder and Head of Sales, Thomas is now primarily responsible for the distribution of the company’s products and the acquisition of new business partners. He also brings his extensive and multifaceted entrepreneurial experience—including research in innovative food ingredients—into the areas of business development and strategic growth at SBR Development Holding.
Sven Reinwein
After graduating from high school, Sven Reinwein began studying law at the University of Vienna. While still a student, he gained early professional experience working with various companies in the e-commerce sector. In 2015, he co-founded cannhelp GmbH together with Philip and Thomas, and served as managing director for several years. Since 2021, Sven has focused on his strategic and administrative role within the company, contributing his extensive entrepreneurial experience to the ongoing development and growth of cannhelp GmbH.
lek.dent. Hanno Senger D.D.S.
Dr. Hanno Senger is a Vienna-based dentist and shareholder of SBR Development Holding, a company dedicated to medical and pharmaceutical innovation. In 2022, he took over his family’s dental practice—now in its third generation—after previously working as a dentist since 2016. His clinic provides a wide range of services, including aesthetic dentistry, restorative treatments, endodontics, prosthodontics, periodontal therapy, implantology, and holistic care. Dr. Senger has a strong interest in the application of cannabidiol (CBD) in dental medicine, particularly in the areas of inflammation control and bone regeneration. In addition to his clinical work, he is committed to global health initiatives. In partnership with Make Me Smile Kenya, he has led free dental treatment camps and oral hygiene education programs for children in underserved communities.
Dominik Stibi
Dominik Stibi is a licensed attorney and founder of DOS Law. Prior to establishing his own law firm, he was a partner at the Weisenheimer group. He has gained his expertise at some of the most renowned law firms in Vienna and Asia. During his academic years, he worked for the law firm Kosesnik-Wehrle und Langer, which specializes in insolvency and consumer law, as a legal associate, and served as a research assistant at the Institute for Constitutional and Administrative Law under em. Univ.-Prof. Dr. Bernd‑Christian Funk. He completed his legal training with Brauneis Klauser Prändl, Wolf Theiss, and Stock Rafaseder Gruszkiewicz. His clients include numerous innovative start-ups, especially in the pharmaceutical, cannabis and IT sectors, whom he advises and represents in all areas of Austrian and international business law. He is a graduate of the University of Vienna’s Faculty of Law and ranked among the top of his class.
INVEST in the future of cannabinoids
SBR Development Holding is a private company based in Austria. We are open for dialog – please reach out to us!